Verrica Pharmaceuticals (VRCA) Competitors $3.85 -0.10 (-2.53%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$3.89 +0.04 (+1.04%) As of 10/24/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VRCA vs. FBRX, ARTV, CRDF, ACOG, CTOR, TCRX, BTMD, TVGN, ANIX, and CLYMShould you be buying Verrica Pharmaceuticals stock or one of its competitors? The main competitors of Verrica Pharmaceuticals include Forte Biosciences (FBRX), Artiva Biotherapeutics (ARTV), Cardiff Oncology (CRDF), Alpha Cognition (ACOG), Citius Oncology (CTOR), TScan Therapeutics (TCRX), biote (BTMD), Tevogen Bio (TVGN), Anixa Biosciences (ANIX), and Climb Bio (CLYM). These companies are all part of the "pharmaceutical products" industry. Verrica Pharmaceuticals vs. Its Competitors Forte Biosciences Artiva Biotherapeutics Cardiff Oncology Alpha Cognition Citius Oncology TScan Therapeutics biote Tevogen Bio Anixa Biosciences Climb Bio Forte Biosciences (NASDAQ:FBRX) and Verrica Pharmaceuticals (NASDAQ:VRCA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, valuation, analyst recommendations, institutional ownership, earnings and risk. Do insiders and institutionals hold more shares of FBRX or VRCA? 77.6% of Forte Biosciences shares are held by institutional investors. Comparatively, 42.5% of Verrica Pharmaceuticals shares are held by institutional investors. 5.9% of Forte Biosciences shares are held by insiders. Comparatively, 54.0% of Verrica Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has higher valuation & earnings, FBRX or VRCA? Forte Biosciences has higher earnings, but lower revenue than Verrica Pharmaceuticals. Forte Biosciences is trading at a lower price-to-earnings ratio than Verrica Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioForte BiosciencesN/AN/A-$35.48M-$16.29-0.74Verrica Pharmaceuticals$7.57M4.81-$76.58M-$8.28-0.46 Do analysts rate FBRX or VRCA? Forte Biosciences currently has a consensus target price of $68.00, suggesting a potential upside of 461.52%. Verrica Pharmaceuticals has a consensus target price of $20.00, suggesting a potential upside of 419.48%. Given Forte Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Forte Biosciences is more favorable than Verrica Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Forte Biosciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Verrica Pharmaceuticals 1 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.75 Does the media refer more to FBRX or VRCA? In the previous week, Verrica Pharmaceuticals had 6 more articles in the media than Forte Biosciences. MarketBeat recorded 8 mentions for Verrica Pharmaceuticals and 2 mentions for Forte Biosciences. Forte Biosciences' average media sentiment score of 1.48 beat Verrica Pharmaceuticals' score of 1.09 indicating that Forte Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Forte Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Verrica Pharmaceuticals 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is FBRX or VRCA more profitable? Verrica Pharmaceuticals' return on equity of 0.00% beat Forte Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Forte BiosciencesN/A -85.38% -72.34% Verrica Pharmaceuticals N/A N/A -115.48% Which has more volatility and risk, FBRX or VRCA? Forte Biosciences has a beta of 3.03, indicating that its share price is 203% more volatile than the S&P 500. Comparatively, Verrica Pharmaceuticals has a beta of 1.71, indicating that its share price is 71% more volatile than the S&P 500. SummaryForte Biosciences beats Verrica Pharmaceuticals on 8 of the 14 factors compared between the two stocks. Get Verrica Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRCA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRCA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRCA vs. The Competition Export to ExcelMetricVerrica PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.31M$2.97B$6.23B$10.66BDividend YieldN/A57.75%5.71%4.82%P/E Ratio-0.4625.2430.2030.21Price / Sales4.81782.34590.34132.63Price / CashN/A168.3237.0161.44Price / Book-3.605.6512.046.60Net Income-$76.58M$33.06M$3.32B$276.82M7 Day Performance-7.23%3.15%1.89%2.58%1 Month Performance-5.87%8.13%7.68%3.76%1 Year Performance-74.50%-2.49%56.01%33.84% Verrica Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRCAVerrica Pharmaceuticals3.9201 of 5 stars$3.85-2.5%$20.00+419.5%-74.3%$37.31M$7.57M-0.4640Positive NewsAnalyst ForecastFBRXForte Biosciences3.0093 of 5 stars$12.19+0.9%$68.00+457.8%+158.2%$150.19MN/A-0.755News CoverageShort Interest ↑ARTVArtiva Biotherapeutics3.9105 of 5 stars$4.91-18.3%$18.25+271.7%-46.8%$146.80M$250K0.0081Gap UpCRDFCardiff Oncology2.3437 of 5 stars$2.28+4.1%$10.63+366.0%-18.3%$145.69M$680K-2.6220News CoverageAnalyst ForecastGap UpACOGAlpha Cognition2.6548 of 5 stars$7.13+4.9%$18.00+152.5%N/A$142.13M$4.59M-4.46N/AShort Interest ↑Analyst RevisionCTORCitius Oncology2.0684 of 5 stars$1.79+5.3%$6.00+235.2%+39.8%$141.97MN/A0.00N/ANews CoverageAnalyst ForecastGap UpHigh Trading VolumeTCRXTScan Therapeutics2.8589 of 5 stars$2.52+1.6%$7.80+209.5%-53.5%$140.74M$6.96M-2.31100BTMDbiote2.1589 of 5 stars$2.93+3.2%$6.00+104.8%-42.4%$140.41M$197.19M3.26194News CoverageAnalyst UpgradeTVGNTevogen Bio2.6797 of 5 stars$0.700.0%$10.00+1,325.9%-74.0%$138.01MN/A-3.693News CoverageAnalyst ForecastANIXAnixa Biosciences3.2117 of 5 stars$4.29+4.6%$9.00+109.8%+31.4%$134.96M$210K-12.265Gap UpCLYMClimb Bio3.6405 of 5 stars$2.32+20.2%$9.20+296.6%N/A$130.79MN/A-3.319Analyst ForecastGap Up Related Companies and Tools Related Companies FBRX Alternatives ARTV Alternatives CRDF Alternatives ACOG Alternatives CTOR Alternatives TCRX Alternatives BTMD Alternatives TVGN Alternatives ANIX Alternatives CLYM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRCA) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verrica Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verrica Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRCA Stock Alerts